GENOMIC HEALTH, INC.
REDWOOD CITY, CA

Genomic Health, Inc. is a pioneering company in the field of cancer diagnostics, with a mission to revolutionize treatment decisions and outcomes through clinically actionable diagnostics and services. Headquartered in Redwood City, Florida, the company was incorporated on March 17, 2004, and has since made significant strides in precision medicine. Genomic Health aims to eliminate the 'one-size-fits-all' approach in cancer care by providing personalized diagnostic solutions such as the Oncotype IQ portfolio of products. The company is dedicated to making its Oncotype DX tests accessible worldwide, including covering over 260 million lives outside the U.S., and ensuring Medicare reimbursement for the Oncotype DX prostate cancer test within the U.S. Genomic Health's commitment extends beyond product innovation; it focuses on transforming patient treatment to improve outcomes significantly. Under the leadership of CEO Kevin T Conroy, Chief Financial Officer Aaron Bloomer, and Director James Herriott, Genomic Health continues to inspire its workforce with meaningful work in life-changing cancer diagnostics. The company maintains communication via multiple channels with contact numbers including (650) 569-2281 and a mailing address at 5505 Endeavor Lane, Madison, WI, 53719, US. More information can be found on their website: genomichealth.com.